ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1311

Causative Pathogens, Antibiotic Susceptibility, and Characteristics of Patients with Bacterial Septic Arthritis over Time

Sadao Jinno1, Carol Sulis2 and Maureen Dubreuil3,4, 1Rheumatology, Boston University School of Medicine, Boston, MA, 2infectious disease, Boston University School of Medicine, Boston, MA, 3Rheumatology, Boston VA HealthCare System, Boston, MA, 4Clinical Epidemiology, Boston University School of Medicine, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Infection

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Infection-related Rheumatic Disease - Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Management of septic arthritis remains a challenge. The emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains with reduced vancomycin susceptibility and multi drug resistant (MDR) gram negative bacilli (GNB) further complicates treatment. However, no information is available for the incidence and outcomes of septic arthritis due to these organisms.   

Methods: We performed a retrospective chart review of all inpatient cases of septic arthritis with positive synovial cultures from 2000 to 2015 at a tertiary medical center. MDR was defined for GNB as resistance to two or more classes/groups of antibiotics. We compared patient demographics, clinical information, antibiotic resistance patterns, and clinical outcomes between the early period (2000-07) and the later period (2008-2015) using Mann Whitney and chi-square tests. 

Results: There were 128 cases of septic arthritis; 52 in the period 2000-2007 and 76 in the period 2008-2015. The proportion of MRSA septic arthritis did not differ significantly between the first and second period (17% vs 20% of cases, p-value 0.73) while there was a trend toward more cases of GNB in the second period (4% vs 11%, p-value 0.20). One patient had septic arthritis due to MRSA with a vancomycin minimum inhibitory concentration (MIC) ≥ 1.5 ug/mL in each period. There was only 1 case of MDR GNB in the later period. Median length of stay (LOS) was similar between methicillin-sensitive Staphylococcus aureus (MSSA) and MRSA (11 days vs 14 days, p=0.59), but higher than other organisms including streptococci and GNB (p=0.02). The most common joint involved was knee (55%) followed by hip (14%).  Six out of 8 (75%) cases of polyarticular septic arthritis occurred in patients with MSSA. In-hospital mortality rate of MSSA and MRSA septic arthritis was 6.7% and 8.3 % respectively while no deaths occurred in patients with streptococci and GNB septic arthritis.

Conclusion: The distribution and sensitivity of pathogens causing septic arthritis, including MRSA and MDR GNB, did not differ between the two study periods in this single-center study. The patient with MDR GNB developed severe sepsis requiring intensive care unit admission. The outcomes of MRSA septic arthritis, including increased vancomycin MIC, did not differ significantly from MSSA septic arthritis.     Figure

          Table  Outcomes of septic arthritis across different organisms  

 

MSSA a

(N=60)

MRSA b

(N=24)

CoNS c

(N=7)

Streptococci

(N=22)

Gram negative bacilli

(N=10)

Concomitant Endocarditis, n (%)

6 (9.7)

2 (8.3)

0

0

0

Sepsis d, n (%)

30 (51.7)

13 (56.5)

0

5 (22.7)

1 (10.0)

Surgical intervention

48 (81.4)

19 (82.6)

7 (100)

5 (68.2)

10 (100)

ICU stay, n (%)

15 (25.4)

7 (29.1)

1 (14.3)

5 (22.7)

1 (10.0)

Length of stay  [IQR]

11 [8-16]

14 [7-19]

9 [8-11]

 9 [5-14]

7 [7-12]

Death, n (%)

4 (6.7)

2 (8.3)

0

0

0

Data are no. (%) patients, unless otherwise indicated. a. MSSA: methicillin-sensitive Staphylococcus aureus. b. MRSA: methicillin-resistant Staphylococcus aureus, c. CoNS: coagulase negative staphylococci, d. two or more systemic inflammatory response syndrome criteria.

   


Disclosure: S. Jinno, None; C. Sulis, None; M. Dubreuil, None.

To cite this abstract in AMA style:

Jinno S, Sulis C, Dubreuil M. Causative Pathogens, Antibiotic Susceptibility, and Characteristics of Patients with Bacterial Septic Arthritis over Time [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/causative-pathogens-antibiotic-susceptibility-and-characteristics-of-patients-with-bacterial-septic-arthritis-over-time/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/causative-pathogens-antibiotic-susceptibility-and-characteristics-of-patients-with-bacterial-septic-arthritis-over-time/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology